Vasculitis & polymyalgia rheumatica

Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying

Ann Rheum DisPublished Cohort study of federated registries

Authors' conclusion

In the largest reported AAV cohort-study, we federated patient registries using semantic web technologies and highlighted concerns about data quality. The comparison of patient characteristics, treatment and outcomes was hampered by heterogeneous recruitment settings.

Study context

Population
Patients with antibody-associated vasculitis (AAV) across six federated European registriescases of AAV
Participants
5,282 patients
Outcome
Data quality, characteristics, treatment and outcomes
Methodological detailssix federated AAV registries, semantic interoperability via FAIRVASC ontology, SPARQL federated querying, random effects meta-analysis
  • Six federated AAV registries
  • Semantic interoperability via FAIRVASC ontology
  • SPARQL federated querying
  • Random effects meta-analysis

Main finding

As reported in the abstract

Uniqueness and data-type consistency
100%
Completeness
49%-100%
Correctness
60%-100%
Granulomatosis with polyangiitis (GPA)
2754 (52.1%)
MPA
1580 (29.9%)
EGPA
937 (17.7%)
Lung involvement
3281 (65.1%)
Ear-nose-throat involvement
2860 (56.7%)
Kidney involvement
2534 (50.2%)
IV CYC remission induction
982 (50.7%)
RTX remission induction
505 (17.7%)
Pulsed IV GC use (highly variable)
11%-91%
Overall mortality per 1000 patient-years
28.8 (95% CI 19.7 to 42.2)
End-stage kidney disease incidence per 1000 patient-years
24.8 (95% CI 19.7 to 31.1)

Observational data: associations, not effects.

Original publication

Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying. Ann Rheum Dis. Published 2 January 2024. doi:10.1136/ard-2023-224571

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.